Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by polo11on Sep 27, 2016 1:11pm

169 Views

Post# 25282231

RE:RE:RE:RE:RE:POLO11 has nothing to do with this company

Can everyone stop - I will clarify;

Stephen Kilmer is and is the only IR and media relation for Genenews.
I was hire as a communication corporate advisor to setup and improve internaly at Genenews their financial communication department. My dutie will be in support of Stephen effort. Voice mail should say for financial communication department, please press # 1.

We are working in synergie; and our role are clearly define. period.

Bearish1 wrote: Lithlover, don't have to discredit anyone. The real Investor Relations guy, on the company payroll, will set you straight about your claim. I challange to call him. His name and phone is on Gen's website he knows nothing about any corporate adviser of communication. Give your head a shake. Don't you think Stephen would know what is going on with the company? Great story though. Gullible, is all I can say.

Having said that, I do think this will turn out to be a good investment. Just don't like the confusion that happens after a 100% move. .

All I can say is call the Investor Relations Stephen Kilmer 647 872 4849 on the GeneNews site. He will get back to you.